These findings highlight the challenges in managing AD with conventional systemic therapies and underscore the need for improved treatment strategies. Insights into the patterns of systemic therapy use and disease control can inform future therapeutic approaches and policy decisions to enhance patient outcomes in AD management.
Schwedhelm et al. (Mon,) studied this question.